At the time of writing, Haemonetics Corp [HAE] stock is trading at $71.24, up 3.37%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HAE shares have gain 4.32% over the last week, with a monthly amount drifted -11.01%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Haemonetics Corp [NYSE: HAE] stock has seen the most recent analyst activity on December 06, 2024, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $116. Previously, Raymond James upgraded its rating to Strong Buy on November 08, 2024, and kept the price target unchanged to $120. On September 13, 2024, CL King initiated with a Buy rating and assigned a price target of $116 on the stock. BofA Securities started tracking the stock assigning a Neutral rating and suggested a price target of $85 on September 11, 2024. BTIG Research initiated its recommendation with a Buy and recommended $112 as its price target on September 10, 2024. Needham upgraded its rating to Buy for this stock on June 12, 2024, but kept the price target unchanged to $112. In a note dated October 13, 2022, Mizuho initiated an Buy rating and provided a target price of $90 on this stock.
For the past year, the stock price of Haemonetics Corp fluctuated between $65.73 and $97.97. Currently, Wall Street analysts expect the stock to reach $107 within the next 12 months. Haemonetics Corp [NYSE: HAE] shares were valued at $71.24 at the most recent close of the market. An investor can expect a potential return of 50.2% based on the average HAE price forecast.
Analyzing the HAE fundamentals
According to Haemonetics Corp [NYSE:HAE], the company’s sales were 1.36B for trailing twelve months, which represents an 8.59% jump. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.15 points at the first support level, and at 67.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 72.42, and for the 2nd resistance point, it is at 73.60.
Ratios To Look Out For
It is important to note that Haemonetics Corp [NYSE:HAE] has a current ratio of 3.49. Further, the Quick Ratio stands at 2.09, while the Cash Ratio is 1.09. Considering the valuation of this stock, the price to sales ratio is 2.63, the price to book ratio is 4.08 and price to earnings (TTM) ratio is 29.59.
Transactions by insiders
Recent insider trading involved Lingamneni Anila, Former Officer, that happened on Nov 11 ’24 when 6238.0 shares were purchased. President, Global Hospital, Strong Stewart W completed a deal on Jul 26 ’24 to sell 4312.0 shares. Meanwhile, Officer Strong Stewart W bought 4312.0 shares on Jul 26 ’24.
